Q3 2019 Holdings
Filed 2019-11-14 | 33 holdings | $513.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $189.8M | 1,970,000 | 36.9% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $164.3M | 2,437,100 | 32.0% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $95.2M | 835,000 | 18.5% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $31.9M | 887,500 | 6.2% |
| Allogene Therapeutics Inc(ALLO) | Common | 019770106 | $30.8M | 1,128,594 | 6.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $292.2K | 3,750,000 | 0.1% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $278.5K | 21,000,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $192.9K | 10,601,039 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $129.2K | 8,520,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $126.4K | 1,678,000 | 0.0% |
| Horizon Therapeutics PLC | Common | G46188101 | $108.9K | 4,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $89.0K | 11,100,000 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $81.0K | 1,552,700 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $75.1K | 1,875,000 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $71.7K | 5,890,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $67.9K | 2,200,000 | 0.0% |
| Pacira Biosciences Inc(PCRX) | Common | 695127100 | $60.9K | 1,600,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | Common | 48576U106 | $58.2K | 6,050,000 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $48.5K | 1,000,000 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $31.3K | 7,424,867 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $31.0K | 360,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $23.2K | 4,250,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $23.1K | 684,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $21.6K | 2,400,000 | 0.0% |
| Medicines Co | Common | 584688105 | $18.6K | 371,623 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $14.4K | 365,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $13.8K | 2,700,000 | 0.0% |
| Kodiak Sciences Inc(KOD) | Common | 50015M109 | $7.2K | 500,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $5.3K | 1,105,999 | 0.0% |
| Teligent Inc | Common | 87960W104 | $5.0K | 5,231,206 | 0.0% |
| Turning Point Therapeutics Inc | Common | 90041T108 | $3.8K | 100,000 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $3.5K | 6,240,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $3.3K | 285,714 | 0.0% |